Pharmaceutical compositions comprising 1-(3-cyano-1-isopropyl-indol-5-yl) pyrazol-4-carboxylic acid

The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl) pyrazol-4-carboxylic acid, or a pharmaceutically acceptable salt thereof, and to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl) pyrazol-4-carboxylic acid, or a pha...

Full description

Saved in:
Bibliographic Details
Main Authors MIN JI-YOUNG, KIM JUN YU, MOON JUN-SIK, SEO JEONG-YEON, HEE MIN, SHIN SUNG HYE, LEE JI-EUN, KIM MIN-HEE
Format Patent
LanguageChinese
English
Published 19.01.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl) pyrazol-4-carboxylic acid, or a pharmaceutically acceptable salt thereof, and to a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl) pyrazol-4-carboxylic acid, or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using the same. The pharmaceutical composition provided by the invention can effectively reduce the blood uric acid concentration of patients with hyperuricemia-related diseases. 本发明涉及：一种包含1-(3-氰基-1-异丙基-吲哚-5-基)吡唑-4-甲酸或其药学上可接受的盐的药物组合物；以及使用其预防或治疗高尿酸血症相关疾病的方法。根据本发明的药物组合物可有效降低高尿酸血症相关疾病患者的血液尿酸浓度。
Bibliography:Application Number: CN202280039108